Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.

Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol. 2021 12; 22(12):1777-1786.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Circadian Rhythm
Female
Follow-Up Studies
Humans
Immunotherapy
Infusions, Intravenous
Ipilimumab
Longitudinal Studies
Male
Melanoma
Middle Aged
Prognosis
Propensity Score
Retrospective Studies
Skin Neoplasms
Survival Rate

authors with profiles

Chrystal Mary Paulos